The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
IL-10 Signaling Is Essential for 1,25-Dihydroxyvitamin D3-Mediated Inhibition of Experimental Autoimmune Encephalomyelitis
Open accessAbstract
Multiple sclerosis (MS) results from an aberrant, neuroantigen-specific, T cell-mediated autoimmune response. Because MS prevalence and severity decrease sharply with increasing sunlight exposure, and sunlight supports vitamin D3 synthesis, we proposed that vitamin D3 and 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3) may protect against MS. In support of this hypothesis, 1,25-(OH)2D3 strongly inhibited experimental autoimmune encephalomyelitis (EAE). This inhibition required lymphocytes other than the encephalitogenic T cells. In this study, we tested the hypothesis that 1,25-(OH)2D3 might inhibit EAE through the action of IL-10-producing regulatory lymphocytes. We report that vitamin D3 and 1,25-(OH)2D3 strongly inhibited myelin oligodendrocyte peptide (MOG35–55)-induced EAE in C57BL/6 mice, but completely failed to inhibit EAE in mice with a disrupted IL-10 or IL-10R gene. Thus, a functional IL-10-IL-10R pathway was essential for 1,25-(OH)2D3 to inhibit EAE. The 1,25-(OH)2D3 also failed to inhibit EAE in reciprocal, mixed bone marrow chimeras constructed by transferring IL-10-deficient bone marrow into irradiated wild-type mice and vice versa. Thus, 1,25-(OH)2D3 may be enhancing an anti-inflammatory loop involving hemopoietic cell-produced IL-10 acting on brain parenchymal cells and vice versa. If this interpretation is correct, and humans have a similar bidirectional IL-10-dependent loop, then an IL-10-IL-10R pathway defect could abrogate the anti-inflammatory and neuro-protective functions of sunlight and vitamin D3. In this way, a genetic IL-10-IL-10R pathway defect could interact with an environmental risk factor, vitamin D3 insufficiency, to increase MS risk and severity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Practical Statistics for Medical Research
Altman, D. G. (1990) · doi:10.1201/9780429258589 · Cited by 10,668
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737 · cited 2×
“The T and B lymphocytes, infiltrating macrophages, microglial cells, and astrocytes all have the capacity to produce IL-10 (15, 44).”
BackgroundVitamin D: a millenium perspective
Holick, M. F. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10338 · Cited by 1,319
Cited by
Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects
Christakos, S., Dhawan, P., Verstuyf, A., Verlinden, L., & Carmeliet, G. (2016) · Physiological Reviews · doi:10.1152/physrev.00014.2015 · Cited by 1,957
Vitamin effects on the immune system: Vitamins A and D take centre stage
Mora, J. R., Iwata, M., & von Andrian, U. H. (2008) · Nature Reviews Immunology · doi:10.1038/nri2378 · Cited by 1,559
T cell subsets and their signature cytokines in autoimmune and inflammatory diseases
Raphael, I., Nalawade, S., Eagar, T. N., & Forsthuber, T. G. (2015) · Cytokine · doi:10.1016/j.cyto.2014.09.011 · Cited by 1,160
Jeffery, L. E., Burke, F., Mura, M., Zheng, Y., Qureshi, O. S., Hewison, M., Walker, L. S. K., Lammas, D. A., Raza, K., & Sansom, D. M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803217 · Cited by 789
Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors
Ascherio, A., & Munger, K. L. (2007) · Annals of Neurology · doi:10.1002/ana.21141 · Cited by 714
Vitamin D and multiple sclerosis
Ascherio, A., Munger, K. L., & Simon, K. C. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70086-7 · Cited by 576
Vitamin D and 1,25(OH)2D Regulation of T cells
Cantorna, M., Snyder, L., Lin, Y.-D., & Yang, L. (2015) · Nutrients · doi:10.3390/nu7043011 · Cited by 565
Control of autoimmune diseases by the vitamin D endocrine system
Adorini, L., & Penna, G. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0855 · Cited by 557
Immunomodulatory effects of Vitamin D in multiple sclerosis
Correale, J., Ysrraelit, M. C., & Gaitan, M. I. (2009) · Brain · doi:10.1093/brain/awp033 · Cited by 538
Vitamin D and the Immune System: New Perspectives on an Old Theme
Hewison, M. (2010) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2010.02.010 · Cited by 518
Guillot, X., Semerano, L., Saidenberg-Kermanac’h, N., Falgarone, G., & Boissier, M.-C. (2010) · Joint Bone Spine · doi:10.1016/j.jbspin.2010.09.018 · Cited by 466
Joshi, S., Pantalena, L.-C., Liu, X. K., Gaffen, S. L., Liu, H., Rohowsky-Kochan, C., Ichiyama, K., Yoshimura, A., Steinman, L., Christakos, S., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05020-11 · Cited by 458
Vitamin D3: a helpful immuno-modulator: Vitamin D3 as immuno-modulator
Di Rosa, M., Malaguarnera, M., Nicoletti, F., & Malaguarnera, L. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03482.x · Cited by 447
Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential
Dankers, W., Colin, E. M., van Hamburg, J. P., & Lubberts, E. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00697 · Cited by 442
Vitamin D and immune function: an overview
Hewison, M. (2012) · Proceedings of the Nutrition Society · doi:10.1017/s0029665111001650 · Cited by 419
Modulation of inflammatory and immune responses by vitamin D
Colotta, F., Jansson, B., & Bonelli, F. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.07.007 · Cited by 399
Vitamin D and Immune Regulation: Antibacterial, Antiviral, Anti‐Inflammatory
L Bishop, E., Ismailova, A., Dimeloe, S., Hewison, M., & White, J. H. (2021) · JBMR Plus · doi:10.1002/jbm4.10405 · Cited by 392
Vitamin D, a neuro-immunomodulator: Implications for neurodegenerative and autoimmune diseases
Fernandes de Abreu, D. A., Eyles, D., & Féron, F. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.05.023 · Cited by 375
The development and function of regulatory T cells
Workman, C. J., Szymczak-Workman, A. L., Collison, L. W., Pillai, M. R., & Vignali, D. A. A. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0026-2 · Cited by 344
Impact of Childhood Malnutrition on Host Defense and Infection
Ibrahim, M. K., Zambruni, M., Melby, C. L., & Melby, P. C. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00119-16 · Cited by 344
Vitamin D as an immune modulator in multiple sclerosis, a review
Smolders, J., Damoiseaux, J., Menheere, P., & Hupperts, R. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.11.014 · Cited by 317
1,25‐dihydroxyvitamin D 3 promotes IL‐10 production in human B cells
Heine, G., Niesner, U., Chang, H., Steinmeyer, A., Zügel, U., Zuberbier, T., Radbruch, A., & Worm, M. (2008) · European Journal of Immunology · doi:10.1002/eji.200838216 · Cited by 311
Mechanisms Underlying the Regulation of Innate and Adaptive Immunity by Vitamin D
Wei, R., & Christakos, S. (2015) · Nutrients · doi:10.3390/nu7105392 · Cited by 302
The interplay between vitamin D and viral infections
Teymoori‐Rad, M., Shokri, F., Salimi, V., & Marashi, S. M. (2019) · Reviews in Medical Virology · doi:10.1002/rmv.2032 · Cited by 279
Vitamin D and the Immune System: New Perspectives on an Old Theme
Hewison, M. (2012) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2012.03.012 · Cited by 263
Metadata
- Authors
- Spach, K. M., Nashold, F. E., Dittel, B. N., & Hayes, C. E.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-11-01
- Volume
- 177
- Issue
- 9
- Pages
- 6030-6037
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2167966766
- Cited by
- 206
- References
- 4
- FWCI
- 7.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.